Filing Details
- Accession Number:
- 0001190725-17-000150
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-09-18 19:48:17
- Reporting Period:
- 2017-09-15
- Accepted Time:
- 2017-09-18 19:48:17
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1576263 | Mirati Therapeutics Inc. | MRTX | Pharmaceutical Preparations (2834) | 462693615 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1599324 | Jamie Christensen | C/O Mirati Therapeutics, Inc. 9393 Towne Centre Drive, Suite 200 San Diego CA 92121 | Svp, Chief Science Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2017-09-15 | 770 | $12.00 | 2,670 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2017.
- Includes 772 shares acquired under the ESPP Purchase on 05/31/17.
Billionaire Hedge Funds
